Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication.

@article{Lori1994HydroxyureaAA,
  title={Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication.},
  author={Franco Lori and Andrei G. Malykh and A Faillace Cara and Deming Sun and John N. Weinstein and Julianna Lisziewicz and RobertC. Gallo},
  journal={Science},
  year={1994},
  volume={266 5186},
  pages={
          801-5
        }
}
Hydroxyurea, a drug widely used in therapy of several human diseases, inhibits deoxynucleotide synthesis--and, consequently, DNA synthesis--by blocking the cellular enzyme ribonucleotide reductase. Hydroxyurea inhibits human immunodeficiency virus-type 1 (HIV-1) DNA synthesis in activated peripheral blood lymphocytes by decreasing the amount of intracellular deoxynucleotides, thus suggesting that this drug has an antiviral effect. Hydroxyurea has now been shown to block HIV-1 replication in… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 80 CITATIONS

FILTER CITATIONS BY YEAR

1996
2018

CITATION STATISTICS

  • 3 Highly Influenced Citations

  • Averaged 2 Citations per year over the last 3 years

  • 100% Increase in citations per year in 2018 over 2017

Similar Papers

Loading similar papers…